Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 4
2010 10
2011 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Development of a second-generation antiandrogen for treatment of advanced prostate cancer.
Tran C, Ouk S, Clegg NJ, Chen Y, Watson PA, Arora V, Wongvipat J, Smith-Jones PM, Yoo D, Kwon A, Wasielewska T, Welsbie D, Chen CD, Higano CS, Beer TM, Hung DT, Scher HI, Jung ME, Sawyers CL. Tran C, et al. Science. 2009 May 8;324(5928):787-90. doi: 10.1126/science.1168175. Epub 2009 Apr 9. Science. 2009. PMID: 19359544 Free PMC article. Clinical Trial.
Critical review of prostate cancer predictive tools.
Shariat SF, Kattan MW, Vickers AJ, Karakiewicz PI, Scardino PT. Shariat SF, et al. Future Oncol. 2009 Dec;5(10):1555-84. doi: 10.2217/fon.09.121. Future Oncol. 2009. PMID: 20001796 Free PMC article. Review.
Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
Gallagher DJ, Gaudet MM, Pal P, Kirchhoff T, Balistreri L, Vora K, Bhatia J, Stadler Z, Fine SW, Reuter V, Zelefsky M, Morris MJ, Scher HI, Klein RJ, Norton L, Eastham JA, Scardino PT, Robson ME, Offit K. Gallagher DJ, et al. Clin Cancer Res. 2010 Apr 1;16(7):2115-21. doi: 10.1158/1078-0432.CCR-09-2871. Epub 2010 Mar 9. Clin Cancer Res. 2010. PMID: 20215531 Free PMC article.
ETS rearrangements and prostate cancer initiation.
Carver BS, Tran J, Chen Z, Carracedo-Perez A, Alimonti A, Nardella C, Gopalan A, Scardino PT, Cordon-Cardo C, Gerald W, Pandolfi PP. Carver BS, et al. Nature. 2009 Feb 12;457(7231):E1; discussion E2-3. doi: 10.1038/nature07738. Nature. 2009. PMID: 19212347 Free PMC article.
An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivo.
Cherrin C, Haskell K, Howell B, Jones R, Leander K, Robinson R, Watkins A, Bilodeau M, Hoffman J, Sanderson P, Hartman G, Mahan E, Prueksaritanont T, Jiang G, She QB, Rosen N, Sepp-Lorenzino L, Defeo-Jones D, Huber HE. Cherrin C, et al. Cancer Biol Ther. 2010 Apr 1;9(7):493-503. doi: 10.4161/cbt.9.7.11100. Epub 2010 Apr 1. Cancer Biol Ther. 2010. PMID: 20139722 Free PMC article.
17 results